Copertina

Trends in hallucinogen‐associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Nicolas Garel, Steven Tate, Kristin Nash, Anna Lembke
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Addiction
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization
di: Laurent Perrault‐Sequeira, et al.
Pubblicazione: (2025)

Is methamphetamine blood concentration in emergency department patients associated with the clinical picture?
di: David McCutcheon, et al.
Pubblicazione: (2025)

Predictors of outpatient treatment engagement following a visit to a specialized emergency department for substance use: A cohort study using high‐resolution electronic health records
di: Danilo Romero, et al.
Pubblicazione: (2026)

Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose
di: Jennifer S. Love, et al.
Pubblicazione: (2026)

Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA
di: Caitlin M. Turner, et al.
Pubblicazione: (2025)

Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial
di: Jinshuo Li, et al.
Pubblicazione: (2024)

The association between alcohol retail access and health care visits attributable to alcohol for individuals with and without a history of alcohol‐related health‐care use
di: Daniel T. Myran, et al.
Pubblicazione: (2024)

Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse
di: Nia Fogelman, et al.
Pubblicazione: (2024)

Trends and patterns of dual use of combustible tobacco and e‐cigarettes among adults in England: A population study, 2016–2024
di: Sarah E. Jackson, et al.
Pubblicazione: (2025)

Emergency department presentations, hospitalisations and police seizure data related to gamma‐hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024
di: Krista J. Siefried, et al.
Pubblicazione: (2025)

Prediction markets: An emerging form of gambling?
di: Benjamin Johnson, et al.
Pubblicazione: (2025)

Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014–2021
di: Joshua A. Barocas, et al.
Pubblicazione: (2024)

High potency cannabis flower use is associated with heavier consumption and risk for cannabis use disorder among young adults in California, United States
di: Michael S. Dunbar, et al.
Pubblicazione: (2025)

The impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine
di: Roman Ivasiy, et al.
Pubblicazione: (2024)

Trends in gamma‐hydroxybutyrate use, harms and treatment in Australia, 2013 to 2024
di: Amy Peacock, et al.
Pubblicazione: (2026)

Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA
di: Hilary L. Surratt, et al.
Pubblicazione: (2026)

Predictors of emergency medical transport refusal following opioid overdose in Washington, DC
di: Ben Turley, et al.
Pubblicazione: (2024)

The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks
di: Nicki Killeen, et al.
Pubblicazione: (2024)

Trends and correlates of current use of illicitly traded tobacco in Australia: Evidence from a decade of national surveys
di: Ara Cho, et al.
Pubblicazione: (2025)

Trends in substance use and related harms among older adults in high‐income countries
di: Rachel Sutherland, et al.
Pubblicazione: (2024)

Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada
di: Shaleesa Ledlie, et al.
Pubblicazione: (2026)

Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA
di: Gary J. Young, et al.
Pubblicazione: (2024)

Can alcohol use explain the increase in educational inequalities in all‐cause mortality after 2010 in the USA? A three‐way interaction analysis
di: Yachen Zhu, et al.
Pubblicazione: (2025)

Changing trends in drug overdose mortality in Spain, 2001–2022
di: Florencia Giné, et al.
Pubblicazione: (2025)

Addiction, Inc.: Medication‐assisted treatment and America's forgotten war on drugs. EmilyDufton, Chicago, Illinois, USA: University of Chicago Press, 2026. ISBN: 9780226750064
di: Kathleen J. Frydl
Pubblicazione: (2026)

Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022
di: Rachael K. Ross, et al.
Pubblicazione: (2024)

Variations in US county‐level trends in buprenorphine use, 2018–2022
di: Taylor W. Lefler, et al.
Pubblicazione: (2025)

Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science. By BenjaminBreen, New York, USA: Grand Central Publishing, 2024, ISBN: 9781538722374
di: Andrea Ens
Pubblicazione: (2025)

Medication effects on cue‐induced craving in the human laboratory are associated with return to heavy drinking in randomized clinical trials for alcohol use disorder: A follow‐up meta‐analysis
di: Steven J. Nieto, et al.
Pubblicazione: (2026)

Questioning methadone split‐dosing for analgesia among hospitalized patients with opioid use disorder
di: Dale Terasaki, et al.
Pubblicazione: (2024)

Low and no alcohol availability and sales in small retailers in Great Britain: A geographic longitudinal analysis from 2018 to 2022
di: Roberto Valiente, et al.
Pubblicazione: (2026)

Substance‐related intrusive memories in cocaine use disorder are different from but associated with craving
di: Amelie Zacher, et al.
Pubblicazione: (2026)

Change of substance‐related hospitalisation in adolescents after cannabis legalisation in Thailand in 2022
di: Sirada Puetpaiboon, et al.
Pubblicazione: (2026)

Heightened mortality risk after a non‐fatal opioid overdose: Risk factors for mortality in the week following emergency treatment
di: Desiree Eide, et al.
Pubblicazione: (2024)

Patterns, reasons and characteristics of e‐cigarette use in Australia: Findings from the 2022–2023 National Drug Strategy Household Survey
di: Carmen C. W. Lim, et al.
Pubblicazione: (2025)

Alcohol approach–avoidance task behavior and brain potentials differentially predict ecologically assessed alcohol craving and consumption in early emerging adulthood
di: Roberto U. Cofresí, et al.
Pubblicazione: (2025)

Cost‐effectiveness of in‐hospital motivational smoking cessation counselling and proactive referral to community‐based follow‐up
di: Karin Pleym, et al.
Pubblicazione: (2026)

The association between gambling frequency and risk of harm: Analysis using health survey data from England and Scotland
di: Esther Moore, et al.
Pubblicazione: (2026)

Associations between modes of cannabis use and cannabis use disorder: Evidence from the 2022 to 2023 United States National Survey on Drug Use and Health
di: Amrit Baral, et al.
Pubblicazione: (2026)

Profiles of youth initiating use of nicotine pouches, vapes and cigarettes: National findings from the Population Assessment of Tobacco and Health (PATH) study, 2022–2023
di: Olufemi Erinoso, et al.
Pubblicazione: (2026)